Nisa Investment Advisors
ZBIO

Nisa Investment Advisors’s Zenas BioPharma ZBIO Stock Holding History

Nisa Investment Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Sell
651
-1,764
-73% -$35.1K ﹤0.01% 2304
2026
Q1 		$47.2K Buy
2,415
+2,300
+2,000% +$51.6K ﹤0.01% 1690
2025
Q4 		$4.18K Hold
115
– – ﹤0.01% 2485
2025
Q3 		$2.55K Hold
115
– – ﹤0.01% 2571
2025
Q2 		$1.11K Buy
115
+87
+311% +$847 ﹤0.01% 2716
2025
Q1 		$221 Buy
+28
New +$219 ﹤0.01% 2915

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Nisa Investment Advisors's ZBIO Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Zenas BioPharma (ZBIO) stake by 73% in Q2 2026, selling an estimated $35.1K and leaving 651 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2304.

Nisa Investment Advisors first reported a position in ZBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $47.2K in Q1 2026. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Nisa Investment Advisors held 651 shares of Zenas BioPharma worth $16.5K as of Q2 2026.
  • Nisa Investment Advisors sold 1,764 Zenas BioPharma shares in Q2 2026, an estimated $35.1K.
  • Zenas BioPharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2304 holding.
  • Nisa Investment Advisors first reported a position in Zenas BioPharma in Q1 2025 and has held it in 6 quarters since.
  • Nisa Investment Advisors's Zenas BioPharma position peaked at $47.2K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.